19. Venous thromboembolism in patients with heart failure

[1]  S. Goldhaber,et al.  Pulmonary embolism in heart failure. , 2008, Circulation.

[2]  Clifford W Colwell,et al.  Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .

[3]  S. Goldhaber,et al.  Heart failure in patients with deep vein thrombosis. , 2008, The American journal of cardiology.

[4]  P. Stein,et al.  Pulmonary embolism as a cause of death in adults who died with heart failure. , 2006, The American journal of cardiology.

[5]  D. Jiménez,et al.  Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. , 2006, The American journal of medicine.

[6]  P. Stein,et al.  Risk of venous thromboembolism in patients hospitalized with heart failure. , 2006, The American journal of cardiology.

[7]  W. Ghali,et al.  Venous thromboembolism according to age: the impact of an aging population. , 2004, Archives of internal medicine.

[8]  J. Attems,et al.  The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population: an autopsy study of 1594 patients , 2004, Wiener Medizinische Wochenschrift.

[9]  M. Komajda,et al.  Thromboembolism in heart failure, old ideas and new challenges , 2001, European journal of heart failure.

[10]  B. Shively.  Deep venous thrombosis prophylaxis in patients with heart disease , 2001, Current cardiology reports.

[11]  M. Samama,et al.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. , 2000, Archives of internal medicine.

[12]  W. Rand,et al.  Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction. , 1998, Journal of the American College of Cardiology.

[13]  M. Domanski,et al.  Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. , 1997, Journal of the American College of Cardiology.

[14]  T. Levine,et al.  Platelet function, thrombin and fibrinolytic activity in patients with heart failure. , 1993, European heart journal.

[15]  D. Hosmer,et al.  A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. , 1991, Archives of internal medicine.

[16]  J. T. ten Cate,et al.  ACQUIRED RISK FACTORS AND DEEP VEIN THROMBOSIS IN SYMPTOMATIC OUT PATIENTS , 1994, Thrombosis and Haemostasis.

[17]  B. McManus,et al.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. , 1987, The American journal of cardiology.

[18]  D. Littmann,et al.  Idiopathic myocardial hypertrophy. , 1958, The American journal of cardiology.

[19]  G. Anderson,et al.  The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure. , 1950, American heart journal.

[20]  W. P. Harvey,et al.  Dicumarol prophylaxis of thromboembolic disease in congestive heart failure. , 1950, The New England journal of medicine.

[21]  P. White,et al.  FEVER IN CONGESTIVE HEART FAILURE , 1940 .